Rob Liskamp studied Chemistry at the University of Nijmegen, The Netherlands and obtained his Ph.D. in Bio-organic Chemistry in 1982 (cum laude). Post-doctoral research (1983-1986) was carried out in The Institute of Cancer Research and Department of Chemistry of Columbia University, New York. From 1986-1993 he was an assistant professor at the University of Leiden. In 1991 he was a visiting professor at the University of California in Los Angeles. In 1994 he became associate professor at Utrecht University and in 1996 professor of Molecular Medicinal Chemistry. In 2012, he was a visiting professor at the Universities of Leeds and Glasgow. In 2013 he was appointed Professor and Chair of Chemical Biology and Medicinal Chemistry at the University of Glasgow he has set up a new award-winning (2015) lab there, while maintaining a guest appointment as professor at the University of Utrecht. Recently he moved back to The Netherlands and became closely involved with Cristal Therapeutics in Maastricht as well as Maastricht University. Research interests included (enzymatic) synthesis of biologically active modified peptides and peptidomimetics, dendrimers, peptide folding, protein mimics including synthetic antibodies and vaccines.He has > 300 publications; 7 reviews, 11 patents/applications; >14,000 citations and an h-index of 58.www.gla.ac.uk/schools/chemistry/staff/robertliskamp/http://www.liskamp-group.org